Cell therapies are revolutionizing the treatment of disease and are poised to transform health outcomes.
Advances in biology and technology have enabled the development of innovation in a more distributed way than ever before: there is a wave of novel therapeutics in academic centers and biotechs around the world looking for partners to advance their inventions.
That’s where we come in.
Our approach is to bring clinical stage therapies through late stage development and commercialization by partnering with innovators at academic medical centers and small biotechs around the world.
Headquartered in San Francisco, CA, the company is backed by seed investment from National Resilience, Inc., Hibiscus BioVentures, and Jumpstart Nova, as well as several high-net-worth individuals.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 535 Mission St, San Francisco,california 94105,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.cellevolve.com/
- Keywords
- Cell therapy, Biotech, Rare diseases.
- HQ
- San Francisco, California
Cellevolve Questions
Cellevolve's website is https://www.cellevolve.com/
Cellevolve's LinkedIn profile is https://www.linkedin.com/company/cellevolve
Cellevolve has
1 employees.
View email and phone details for 1
employees at Cellevolve.
Cellevolve's industry is
Biotechnology Research
Cellevolve's top competitors are
Pinnacle Biotech,
Cryopharm Corporation,
Pharmaceutix,
Big Pharma Sharma,
Gabaeron,
Cytogroup Inc,
Across-Medical Llc.,
Portal Innovations,
Epiodyne,
Ctrl Therapeutics.
Cellevolve's categories are Biotechnology Research
Cellevolve's founding year is 2020
